Advertisement
Advertisement
U.S. Markets open in 4 hrs 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

Grapefruit USA, Inc. (GPFT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0127+0.0002 (+1.60%)
At close: 03:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0125
Open0.0125
BidN/A x N/A
AskN/A x N/A
Day's Range0.0120 - 0.0145
52 Week Range0.0120 - 0.0579
Volume538,284
Avg. Volume377,277
Market Cap7.106M
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateApr 26, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for GPFT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GRAPEFRUIT USA INC
    Analyst Report: Becton, Dickinson and CompanyBecton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
  • GlobeNewswire

    Grapefruit USA, Inc. Executes Binding Letter of Intent to Acquire Diagnostic Lab Corporation, Inc., Secure New Financing

    LOS ANGELES and DESERT HOT SPRINGS, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, announces today the execution of a binding letter of intent (“LOI”), entered into on June 30, 2022, by the Company and Diagnostic Lab Corporation of Englewood Cliffs, New Jersey, (“DLC”) a diversified food and agriculture safety company, pursuant to which the Company and DLC will

  • GlobeNewswire

    Grapefruit USA, Inc. Issues Update on Proposed Strategic Acquisition

    LOS ANGELES and DESERT HOT SPRINGS, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, is providing an update on its previously announced execution of a Memorandum of Understanding (“MOU”) with Diagnostic Lab Corporation of Englewood Cliffs, New Jersey, (“DLC”) a diversified food and agriculture safety company, concerning Grapefruit’s acquisition of DLC. The Company

  • GlobeNewswire

    Grapefruit USA, Inc. California Cannabis Distributor License Renewed in Record Time

    LOS ANGELES and DESERT HOT SPRINGS, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, announces today that its cannabis distributor license number C11-0000082-LIC has been renewed through May 13, 2023, by the California Department of Cannabis Control. This the quickest annual renewal for the Company since its original distribution license was issued in January 201

Advertisement
Advertisement